Confused jury prompts Wyeth appeal

Was the jury confused? Apparently so. When a Nevada jury decided in favor of three women who claimed that the company's hormone replacement drugs caused their breast cancer, some jurors thought the $134.5 million awarded included punitive damages. It didn't.

The judge sent the jury back to the drawing board. Compensatory damages: $35 million. After the subsequent punitive phase, the jury tacked on another $99 in punitive damages. No harm, no foul? Not so fast. Wyeth says the confusion strengthens its inevitable appeal.

- see Wyeth's release
- check out the article from CNN Money

Related Articles:
Jury fines Wyeth $134.5M in hormone suit. Report
Jurors deliberate in Prempro trial. Report
Wyeth want end to customized HRT treatments. Report
HRT doesn't protect women from heart disease. Report

Read more on: Wyeth

Suggested Articles

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.